← Browse by Condition

Medical Condition

alcohol use disorder

Total Trials

23

Recruiting Now

23

Trial Phases

Phase 2, Phase 1, Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for alcohol use disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — alcohol use disorder Clinical Trials

How many clinical trials are currently recruiting for alcohol use disorder?

ClinicalMetric currently tracks 23 actively recruiting clinical trials for alcohol use disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 23. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for alcohol use disorder?

alcohol use disorder research spans Phase 1 (2 trials), Phase 2 (6 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a alcohol use disorder clinical trial?

Eligibility criteria for alcohol use disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

2

Phase 2

6

Top Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA) 2 trials

CHU de Reims 2 trials

University of Calgary 1 trial

Washington State University 1 trial

National Institute on Drug Abuse (NIDA) 1 trial

Recruiting Clinical Trials

NCT05995769 Phase 2

Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder

University of Calgary

TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)

Washington State University

NCT06015893 Phase 2

Semaglutide Therapy for Alcohol Reduction (STAR)

National Institute on Drug Abu...

Alcohol Research in HIV: Relapse Prevention

Johns Hopkins University

NCT07325266 Phase 2

Human Laboratory Study of Apremilast for Alcohol Use Disorder

National Institute on Alcohol ...

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

Zealand University Hospital

tAN for Substance Use Disorder

Spark Biomedical, Inc.

NIAAA Natural History Protocol

National Institute on Alcohol ...

Social Cognition in Severe Alcohol Use Disorder

Brief Family Involved Treatment Telehealth

Medical University of South Ca...

NCT06405607 Phase 2

Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial

University of Iowa

Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment

Kaiser Permanente

NCT04066192 Phase 2

Brexpiprazole in Alcohol Use Disorder

University of Colorado, Denver

Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool

University Hospital, Montpelli...

Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

VA Palo Alto Health Care Syste...

Effect of Adapted Physical Activity on Sleep Quality in People With Alcohol Use Disorder

Centre Hospitalier Universitai...

NCT05988632 Phase 1, Phase 2

Intranasal Insulin for Treatment of Alcohol Use Disorder

Brown University

Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention

Shirish S Barve

Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments

San Diego State University

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)

United States, Israe...

Self-Concept and Autobiographical Memory in Alcohol Use Disorder

NCT07223983 Phase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

Yale University

Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

Boston University

Related Conditions

alcohol abuse (5) alcoholism (4) opioid use disorder (2) addiction (2) substance use disorders (2) alcohol dependence (2) hiv infections (2) hiv (1) alcohol misuse (1) liver diseases alcoholic (1) treatment adherence (1) liver disease alcohol related (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology